BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27643871)

  • 1. Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors.
    Caocci G; Vacca A; Piras E; Serreli V; Dessi C; Marcias M; Risso P; La Nasa G
    Bone Marrow Transplant; 2016 Dec; 51(12):1640-1641. PubMed ID: 27643871
    [No Abstract]   [Full Text] [Related]  

  • 2. Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia.
    Locatelli F; De Stefano P
    Haematologica; 2005 Dec; 90(12):1592-4. PubMed ID: 16330431
    [No Abstract]   [Full Text] [Related]  

  • 3. Being a haematopoietic stem cell donor for a sick sibling: Adult donors' experiences prior to donation.
    Kisch A; Bolmsjö I; Lenhoff S; Bengtsson M
    Eur J Oncol Nurs; 2015 Oct; 19(5):529-35. PubMed ID: 25813531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the allogeneic transplantation for thalassemia.
    Lucarelli G; Gaziev J
    Blood Rev; 2008 Mar; 22(2):53-63. PubMed ID: 18039551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan.
    Hussein AA; Al-Zaben A; Khattab E; Haroun A; Frangoul H
    Pediatr Transplant; 2016 Feb; 20(1):120-3. PubMed ID: 26493691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
    Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
    Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated donor stem cell transplantation in adult patients with thalassemia.
    La Nasa G; Caocci G; Argiolu F; Giardini C; Locatelli F; Vacca A; Orofino MG; Piras E; Addari MC; Ledda A; Contu L
    Bone Marrow Transplant; 2005 Dec; 36(11):971-5. PubMed ID: 16205730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience.
    Goussetis E; Peristeri I; Kitra V; Vessalas G; Paisiou A; Theodosaki M; Petrakou E; Dimopoulou MN; Graphakos S
    Bone Marrow Transplant; 2012 Aug; 47(8):1061-6. PubMed ID: 22080966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-myeloablative allogeneic peripheral stem cell transplantation for multiple myeloma.
    Ma SY; Lie AK; Au WY; Chim CS; Kwong YL; Liang R
    Hong Kong Med J; 2004 Apr; 10(2):77-83. PubMed ID: 15075426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe.
    Oikonomopoulou C; Goussetis E
    Bone Marrow Transplant; 2021 Dec; 56(12):2882-2888. PubMed ID: 34531544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents.
    Hutt D; Nehari M; Munitz-Shenkar D; Alkalay Y; Toren A; Bielorai B
    Bone Marrow Transplant; 2015 Oct; 50(10):1337-42. PubMed ID: 26146807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.